Latest on Pharmaceutical Industry

news

Torrent Pharma buys US firm Bio-Pharm

Torrent Pharmaceuticals has acquired Bio-Pharm, a generic and overthe-counter drugmaker based in Levittown, Pennsylvania, for an undisclosed sum. "This acquisition is an important step for increasing Torrent's pre..Read More...

Lupin launches generic Vibra-Tabs® Tablet in the US

Pharma Major Lupin announced the launch of its Doxycycline Hyclate Tablet USP, 100 mg having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Doxycycline Hyclate Tablet..Read More...

events

23

Pharmaceutical Microbiology UK

Holiday Inn Kensington Forum,
United Kingdom,
SMi Group

23

Social Media in the Pharmaceutical Industry

Holiday Inn Kensington Forum,
United Kingdom,
SMi Group

Press Releases

High Point Clinical Trials Center Announces the Launch of Renal Impairment Clinical Study Offering

High Point Clinical Trials Center HPCTC has successfully launched its latest clinical study offering in Renal Impairment The increasing demand from the pharmaceutical industry to understand the pharmacokinetic impact of .. Read More...

GC Pharma Confirms Phase 2/3 Clinical Trial of New Protein Therapy for Hepatitis B

GC Pharma formerly known as Green Cross Corporation a South Korean biopharmaceutical company today announced that it will proceed with a Phase 23 clinical trial for GC1102 also known as Hepabiggene the company39s investi.. Read More...

Suppliers of the Month

Product Launch

Articles

Videos

Latest Reports

whitepapers

Latest Projects

testimonials

Expert Talk

Bayer Pharmaceuticals

Bayer Pharmaceuticals Christoph Huwe PhD CAAM is a Strategic Alliance Manager Therapeutics at Bayer AG Pharmaceuticals with a focus on the BayerEvotec Endometriosis BayerEvotec Kidney Diseases BayerOncoMed Oncology strategic alliances and the Tuberculosis Drug Accelerator consortium He is also a member of Bayers Alliance. Read More...
Christoph Huwe
Strategic Alliance Manager Therapeutics